Jern Yee Chen1, Mark N Jones2, Sathish Srinivasan3, Timothy J Neal4, W John Armitage5, Stephen B Kaye6. 1. St. Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, United Kingdom. Electronic address: jy_chen79@yahoo.com.au. 2. Statistics and Clinical Studies, NHS Blood and Transplant, Bristol, United Kingdom. 3. Department of Ophthalmology, University Hospital Ayr, Ayr, Scotland. 4. Department of Medical Microbiology, Royal Liverpool University Hospital, Liverpool, United Kingdom. 5. School of Clinical Sciences, University of Bristol, Bristol, United Kingdom. 6. St. Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, United Kingdom.
Abstract
PURPOSE: To determine the incidence of endophthalmitis after penetrating keratoplasty (PK) and patient and donor risk factors. DESIGN: Retrospective cohort study using national transplant registry data. PARTICIPANTS: All corneal transplant recipients (n = 11 320) registered on the United Kingdom Transplant Registry undergoing their first PK between April 1999 and December 2006. METHODS: Patients who developed endophthalmitis were identified on the transplant registry. In addition, cases where the fellow cornea from the same donor had been transplanted were included. Clinical information regarding donor and recipient characteristics, surgical details, and postoperative outcomes were collected and analyzed. In cases where endophthalmitis was reported, the diagnosis was verified by a follow-up supplementary questionnaire to the surgeon. Logistic regression was used to investigate differences in the factors associated with the development of endophthalmitis. MAIN OUTCOME MEASURES: Incidence of endophthalmitis and graft survival. RESULTS: The overall incidence of endophthalmitis occurring after primary PK in the UK was 0.67%. The incidence of endophthalmitis occurring within 6 weeks of surgery was 0.16%. Graft survival after endophthalmitis was 27% (95% confidence interval, 16-38) at 5 years, with a mean best-corrected visual acuity of 1.13 (logarithm of the minimum angle of resolution) for surviving grafts. Factors associated with endophthalmitis were donor cause of death (infection), high-risk cases, and indication for corneal transplantation. CONCLUSION: Endophthalmitis remains a serious issue, with those affected having reduced graft survival and poor visual outcomes. Management of the identified recipient and donor risk factors are important to reduce endophthalmitis risk. In particular, the increased incidence of endophthalmitis when the donor dies of infection requires further explanation and review of current donor eye retrieval and eye bank practices. The delayed presentation of endophthalmitis cases also raises questions regarding possible sequestration of microbes within the corneal tissue and the effect of antimicrobials in storage media.
PURPOSE: To determine the incidence of endophthalmitis after penetrating keratoplasty (PK) and patient and donor risk factors. DESIGN: Retrospective cohort study using national transplant registry data. PARTICIPANTS: All corneal transplant recipients (n = 11 320) registered on the United Kingdom Transplant Registry undergoing their first PK between April 1999 and December 2006. METHODS:Patients who developed endophthalmitis were identified on the transplant registry. In addition, cases where the fellow cornea from the same donor had been transplanted were included. Clinical information regarding donor and recipient characteristics, surgical details, and postoperative outcomes were collected and analyzed. In cases where endophthalmitis was reported, the diagnosis was verified by a follow-up supplementary questionnaire to the surgeon. Logistic regression was used to investigate differences in the factors associated with the development of endophthalmitis. MAIN OUTCOME MEASURES: Incidence of endophthalmitis and graft survival. RESULTS: The overall incidence of endophthalmitis occurring after primary PK in the UK was 0.67%. The incidence of endophthalmitis occurring within 6 weeks of surgery was 0.16%. Graft survival after endophthalmitis was 27% (95% confidence interval, 16-38) at 5 years, with a mean best-corrected visual acuity of 1.13 (logarithm of the minimum angle of resolution) for surviving grafts. Factors associated with endophthalmitis were donor cause of death (infection), high-risk cases, and indication for corneal transplantation. CONCLUSION:Endophthalmitis remains a serious issue, with those affected having reduced graft survival and poor visual outcomes. Management of the identified recipient and donor risk factors are important to reduce endophthalmitis risk. In particular, the increased incidence of endophthalmitis when the donor dies of infection requires further explanation and review of current donor eye retrieval and eye bank practices. The delayed presentation of endophthalmitis cases also raises questions regarding possible sequestration of microbes within the corneal tissue and the effect of antimicrobials in storage media.
Authors: Anna Song; Rashmi Deshmukh; Haotian Lin; Marcus Ang; Jodhbir S Mehta; James Chodosh; Dalia G Said; Harminder S Dua; Darren S J Ting Journal: Front Med (Lausanne) Date: 2021-07-07
Authors: Raffaela Mistò; Laura Giurgola; Francesca Pateri; Elisabetta Frigerio; Anna Limongelli; Jana D'Amato Tóthová Journal: BMJ Open Ophthalmol Date: 2017-11-15
Authors: Kimberly D Tran; Nicolas A Yannuzzi; Nancy Si; Nimesh A Patel; Darlene Miller; Guillermo Amescua; Audina M Berrocal; Harry W Flynn Journal: Am J Ophthalmol Case Rep Date: 2018-01-04
Authors: Tobias Röck; Johanna Landenberger; Michael Buhl; Efdal Yoeruek; Karl Ulrich Bartz-Schmidt; Matthias Bramkamp; Gunnar Blumenstock; Daniel Röck Journal: Medicine (Baltimore) Date: 2018-09 Impact factor: 1.817
Authors: Grażyna Broniek; Ewa Langwińska-Wośko; Małgorzata Sybilska; Jerzy Szaflik; Jacek P Szaflik; Marta Wróblewska Journal: Arch Med Sci Date: 2016-03-31 Impact factor: 3.318